Skip to main content
. 2014 Jul 28;20(28):9281–9285. doi: 10.3748/wjg.v20.i28.9281

Table 1.

American gastroenterology association inflammatory bowel disease performance measures[16]

Performance measures
IBD characteristics
Type
Anatomic location
Activity
Preventive care
Corticosteroid sparing therapy
Bone loss assessment
Influenza immunization
Pneumococcal immunization
Smoking screening and cessation assessment
Testing
Latent tuberculosis testing prior to anti-TNF therapy
Assessment for Hepatitis B prior to anti-TNF therapy
Inpatient care
Clostridium difficile testing in patients with new onset diarrhea
Venous thromboembolism prophylaxis

IBD: Inflammatory bowel disease; TNF: Tumor necrosis factor.